APA (7th ed.) Citation

Engele, V., Vasiliou, V., Wheelwright, S., Sztankay, M., Puglisi, C., Pogoda, K., . . . Oberguggenberger, A. (2025). 2579P Development of a patient-reported outcome measure for individuals at risk for hereditary cancer: Phase I - IIIa of the EORTC QLQ-HCR30. Annals of Oncology, 36, S1384. https://doi.org/10.1016/j.annonc.2025.08.3194

Chicago Style (17th ed.) Citation

Engele, V.I, et al. "2579P Development of a Patient-reported Outcome Measure for Individuals at Risk for Hereditary Cancer: Phase I - IIIa of the EORTC QLQ-HCR30." Annals of Oncology 36 (2025): S1384. https://doi.org/10.1016/j.annonc.2025.08.3194.

MLA (9th ed.) Citation

Engele, V.I, et al. "2579P Development of a Patient-reported Outcome Measure for Individuals at Risk for Hereditary Cancer: Phase I - IIIa of the EORTC QLQ-HCR30." Annals of Oncology, vol. 36, 2025, p. S1384, https://doi.org/10.1016/j.annonc.2025.08.3194.